These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 30183834

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium.
    Spader TB, Venturini TP, Rossato L, Denardi LB, Cavalheiro PB, Botton SA, Santurio JM, Alves SH.
    Rev Iberoam Micol; 2013; 30(3):200-4. PubMed ID: 23402831
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.
    Al-Hatmi AM, Normand AC, Ranque S, Piarroux R, de Hoog GS, Meletiadis J, Meis JF.
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795379
    [Abstract] [Full Text] [Related]

  • 9. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988
    [Abstract] [Full Text] [Related]

  • 10. Epidemiological aspects and characterization of the resistance profile of Fusarium spp. in patients with invasive fusariosis.
    Rosa PDD, Ramirez-Castrillon M, Borges R, Aquino V, Meneghello Fuentefria A, Zubaran Goldani L.
    J Med Microbiol; 2019 Oct; 68(10):1489-1496. PubMed ID: 31419209
    [Abstract] [Full Text] [Related]

  • 11. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
    Swinne D, Watelle M, Nolard N.
    Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD, Kiraz N.
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [Abstract] [Full Text] [Related]

  • 14. Natamycin and Voriconazole Exhibit Synergistic Interactions with Nonantifungal Ophthalmic Agents against Fusarium Species Ocular Isolates.
    Rees CA, Bao R, Zegans ME, Cramer RA.
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010869
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.
    Dannaoui E, Meletiadis J, Tortorano AM, Symoens F, Nolard N, Viviani MA, Piens MA, Lebeau B, Verweij PE, Grillot R, And The Ebga Network.
    J Med Microbiol; 2004 Feb; 53(Pt 2):129-134. PubMed ID: 14729934
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.